the author of nearly 200 publications, book chapters, books, and published proceedings. His research covers a wide range of issues within cancer epidemiology, with particular emphasis on the epidemiology of tobacco-attributable diseases and the potential of NSAIDs as anti-cancer agents.
Daniel Wikler, Ph.D.
Daniel Wikler, Ph.D., is Professor of Ethics and Population Health Department of Population and International Health’s at Harvard School f Public Health. Dr. Wikler’s current research interests are ethical issues in population and international health, including the allocation of health resources, health research involving human subjects, and ethical dilemmas arising in public health practice. He served as the first Staff Ethicist for the World Health Organization, and remains a consultant to several WHO programs. Prof. Wikler was co-founder and second president of the International Association of Bioethics and has served on the advisory boards of the Asian Bioethics Association and the Pan American Health Organization Regional Program in Bioethics. Professor Wikler is presently co-director of the Program on Ethical Issues in International Health Research at the School of Public Health.
Professor Wikler’s published work addresses many issues in bioethics, including issues in reproduction, transplantation, and end-of-life decision-making in addition to population and international health.. His book series, Studies in Philosophy and Health Policy, was published by Cambridge University Press, as was From Chance to Choice: Genetics and Justice, co-authored by Prof. Wikler and three other philosophers. While at the World Health Organization, he instituted an international collaboration among philosophers and economists on ethical, methodological, and philosophical issues raised by WHO’s work in measurement of the global burden of disease and in developing methods for improving health resource allocation. He will be a core faculty member in the new Harvard Program in Ethics and Health and participates in faculty research and curriculum development groups on such issues as disparities in health status and the impact of corruption and fraud on public health.